103 related articles for article (PubMed ID: 30891745)
1. MIR29B mediates epigenetic mechanisms of HBG gene activation.
Starlard-Davenport A; Smith A; Vu L; Li B; Pace BS
Br J Haematol; 2019 Jul; 186(1):91-100. PubMed ID: 30891745
[TBL] [Abstract][Full Text] [Related]
2. Novel histone deacetylase inhibitor CT-101 induces γ-globin gene expression in sickle erythroid progenitors with targeted epigenetic effects.
Junker LH; Li B; Zhu X; Koti S; Cerbone RE; Hendrick CL; Sangerman J; Perrine S; Pace BS
Blood Cells Mol Dis; 2022 Mar; 93():102626. PubMed ID: 34856533
[TBL] [Abstract][Full Text] [Related]
3. BCL2L1 is associated with γ-globin gene expression.
Dai Y; Shaikho EM; Perez J; Wilson CA; Liu LY; White MR; Farrell JJ; Chui DHK; Sebastiani P; Steinberg MH
Blood Adv; 2019 Oct; 3(20):2995-3001. PubMed ID: 31648320
[TBL] [Abstract][Full Text] [Related]
4. Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: A randomized phase 1 study.
Molokie R; Lavelle D; Gowhari M; Pacini M; Krauz L; Hassan J; Ibanez V; Ruiz MA; Ng KP; Woost P; Radivoyevitch T; Pacelli D; Fada S; Rump M; Hsieh M; Tisdale JF; Jacobberger J; Phelps M; Engel JD; Saraf S; Hsu LL; Gordeuk V; DeSimone J; Saunthararajah Y
PLoS Med; 2017 Sep; 14(9):e1002382. PubMed ID: 28880867
[TBL] [Abstract][Full Text] [Related]
5. Salubrinal induces fetal hemoglobin expression via the stress-signaling pathway in human sickle erythroid progenitors and sickle cell disease mice.
Lopez NH; Li B; Palani C; Siddaramappa U; Takezaki M; Xu H; Zhi W; Pace BS
PLoS One; 2022; 17(5):e0261799. PubMed ID: 35639781
[TBL] [Abstract][Full Text] [Related]
6. HSC and miRNA Regulation with Implication for Foetal Haemoglobin Induction in Beta Haemoglobinopathies.
Okeke C; Silas U; Nnodu O; Clementina O
Curr Stem Cell Res Ther; 2022; 17(4):339-347. PubMed ID: 35189805
[TBL] [Abstract][Full Text] [Related]
7. Research in Sickle Cell Disease: From Bedside to Bench to Bedside.
Salinas Cisneros G; Thein SL
Hemasphere; 2021 Jun; 5(6):e584. PubMed ID: 34095767
[TBL] [Abstract][Full Text] [Related]
8. Association of Inflammatory Biomarker C-Reactive Protein, Lipid Peroxidation and Antioxidant Capacity Marker with HbF Level in Sickle Cell Disease Patients from Chattisgarh.
Bhagat S; Patra PK; Thakur AS
Indian J Clin Biochem; 2012 Oct; 27(4):394-9. PubMed ID: 24082467
[TBL] [Abstract][Full Text] [Related]
9. Large-Scale Drug Screen Identifies FDA-Approved Drugs for Repurposing in Sickle-Cell Disease.
Cannon M; Phillips H; Smith S; Williams K; Brinton L; Gregory C; Landes K; Desai P; Byrd J; Lapalombella R
J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32708954
[TBL] [Abstract][Full Text] [Related]
10. Immune escape of multiple myeloma cells results from low miR29b and the ensuing epigenetic silencing of proteasome genes.
Leone P; Malerba E; Prete M; Solimando AG; Croci GA; Ditonno P; Tucci M; Susca N; Derakhshani A; Dufour A; De Re V; Silvestris N; Racanelli V
Biomark Res; 2024 Apr; 12(1):43. PubMed ID: 38654298
[TBL] [Abstract][Full Text] [Related]
11. Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation.
Basak A; Munschauer M; Lareau CA; Montbleau KE; Ulirsch JC; Hartigan CR; Schenone M; Lian J; Wang Y; Huang Y; Wu X; Gehrke L; Rice CM; An X; Christou HA; Mohandas N; Carr SA; Chen JJ; Orkin SH; Lander ES; Sankaran VG
Nat Genet; 2020 Feb; 52(2):138-145. PubMed ID: 31959994
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia promotes erythroid differentiation through the development of progenitors and proerythroblasts.
Bapat A; Schippel N; Shi X; Jasbi P; Gu H; Kala M; Sertil A; Sharma S
Exp Hematol; 2021 May; 97():32-46.e35. PubMed ID: 33675821
[TBL] [Abstract][Full Text] [Related]
13. BMI1 enables extensive expansion of functional erythroblasts from human peripheral blood mononuclear cells.
Liu S; Wu M; Lancelot M; Deng J; Gao Y; Roback JD; Chen T; Cheng L
Mol Ther; 2021 May; 29(5):1918-1932. PubMed ID: 33484967
[TBL] [Abstract][Full Text] [Related]
14. Erythrocyte microRNAs: a tiny magic bullet with great potential for sickle cell disease therapy.
Verma HK; Ratre YK; Bhaskar LVKS; Colombatti R
Ann Hematol; 2021 Mar; 100(3):607-614. PubMed ID: 33398452
[TBL] [Abstract][Full Text] [Related]
15. Genome editing of HBG1 and HBG2 to induce fetal hemoglobin.
Métais JY; Doerfler PA; Mayuranathan T; Bauer DE; Fowler SC; Hsieh MM; Katta V; Keriwala S; Lazzarotto CR; Luk K; Neel MD; Perry SS; Peters ST; Porter SN; Ryu BY; Sharma A; Shea D; Tisdale JF; Uchida N; Wolfe SA; Woodard KJ; Wu Y; Yao Y; Zeng J; Pruett-Miller S; Tsai SQ; Weiss MJ
Blood Adv; 2019 Nov; 3(21):3379-3392. PubMed ID: 31698466
[TBL] [Abstract][Full Text] [Related]
16. δ-Aminolevulinate induces fetal hemoglobin expression by enhancing cellular heme biosynthesis.
Liu L; Zhu X; Yu A; Ward CM; Pace BS
Exp Biol Med (Maywood); 2019 Oct; 244(14):1220-1232. PubMed ID: 31475864
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenomics of Drugs Used in β-Thalassemia and Sickle-Cell Disease: From Basic Research to Clinical Applications.
Gambari R; Waziri AD; Goonasekera H; Peprah E
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673849
[TBL] [Abstract][Full Text] [Related]
18. Peripheral blood circular RNA circ-0008102 may serve as a novel clinical biomarker in beta-thalassemia patients.
Chen M; Lv A; Zhang S; Zheng J; Lin N; Xu L; Huang H
Eur J Pediatr; 2024 Mar; 183(3):1367-1379. PubMed ID: 38165465
[TBL] [Abstract][Full Text] [Related]
19. Role of microRNA in hydroxyurea mediated HbF induction in sickle cell anaemia patients.
Kargutkar N; Sawant-Mulay M; Hariharan P; Chandrakala S; Nadkarni A
Sci Rep; 2023 Jan; 13(1):369. PubMed ID: 36611033
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA29B induces fetal hemoglobin
Gu Q; Palani CD; Smith A; Li B; Amos-Abanyie EK; Ogu U; Lu L; Pace BS; Starlard-Davenport A
Front Med (Lausanne); 2022; 9():1043686. PubMed ID: 36507536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
